FDA Halts Elevidys Shipments - Search News

Order byBest matchMost fresh

News

Sarepta Therapeutics, FDA

· 8d · on MSN

FDA to Ask Sarepta to Halt Elevidys Shipments After Deaths

Sarepta Therapeutics Inc. said another patient has died from acute liver failure after receiving one of its gene therapies, putting additional pressure on the biotech company after the recent deaths of two teenage boys.

Continue reading

· 8d · on MSN

Sarepta says it won't comply with FDA request to stop shipping gene therapy Elevidys

Sarepta under pressure: FDA requests halt of Elevidys shipments

Clinical Trials Arena on MSN4d

Sarepta halts Elevidys shipments following FDA pressure

Sarepta CEO Doug Ingram said it is important the company maintains a “positive working relationship” with the FDA.

10h

FDA opens probe into mysterious death linked to gene therapy

The Food & Drug Administration is investigating the death of an 8‑year‑old following Elevidys gene therapy for Duchenne ...

BioPharma Dive5d

Sarepta stops Elevidys shipments after standoff with FDA

Company CEO Doug Ingram said the pause was necessary for Sarepta to maintain a "productive and positive working relationship" ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results